Body shape, beyond weight, drives fat stigma for women

February 17, 2021

A woman's body shape--not only the amount of fat--is what drives stigma associated with overweight and obesity.

Fat stigma is a socially acceptable form of prejudice that contributes to poor medical outcomes and negatively affects educational and economic opportunities. But a new study has found that not all overweight and obese body shapes are equally stigmatized. Scientists from Arizona State University and Oklahoma State University have shown that women with abdominal fat around their midsection are more stigmatized than those with gluteofemoral fat on the hips, buttocks and thighs. The work will be published on February 17 in Social Psychology and Personality Science.

"Fat stigma is pervasive, painful and results in huge mental and physical health costs for individuals," said Jaimie Arona Krems, assistant professor of psychology at OSU and first author on the paper. "We found that even when women are the same height and weight, they were stigmatized differently--and this was driven by whether they carried abdominal or gluteofemoral fat. Indeed, in one case, people stigmatized obese women with gluteofemoral fat more than objectively smaller women with abdominal fat. This finding suggests that body shape is sometimes even more important than overall size in driving fat stigma."

The location of fat on the body determines body shape and is associated with different biological functions and health outcomes. Gluteofemoral fat in young women can indicate fertility, while abdominal fat can accompany negative health outcomes like diabetes and cardiovascular disease.

"When people try to understand what others are like, and what characteristics they possess, they often rely on easily visible cues to make their best guesses. We've known for a long time that people use weight as such a cue. Given that different fats, on different parts of the body, are associated with different outcomes, we wanted to explore whether people also systematically use body shape as a cue," said Steven Neuberg, co-author of the study and Foundation Professor and Chair of the ASU Department of Psychology.

To test how the location of fat on the body affected stigma, the research team created illustrations of underweight, average-weight, overweight and obese bodies that varied in both size and shape. The illustrations of higher-weight bodies had either gluteofemoral or abdominal fat.

The study participants stigmatized obese women more than overweight women and also overweight women more than average-weight women. But women with overweight who weighed the same were less stigmatized when they carried gluteofemoral fat than when they carried abdominal fat. This same pattern held for women with obesity, suggesting that body shape, in addition to overall body size, drives stigmatization.

The research team also tested the impact of body shape in driving stigma in different ethnicities and cultures. White and Black Americans, and also participants in India, all showed the same pattern of stigmatizing women carrying abdominal fat.

"The findings from this study are probably not surprising to most women, who have long talked about the importance of shape, or to anyone who has read a magazine article on 'dressing for your shape' that categorizes body shapes as apples, pears, hourglasses and the like," Krems said. "Because theories have not focused on body shape, we haven't tested for its importance and have missed one of the major drivers of fat stigma for some time. It is important to put data to this idea so we can improve interventions for people with overweight and obesity."
-end-


Arizona State University

Related Obesity Articles from Brightsurf:

11 years of data add to the evidence for using testosterone therapy to treat obesity, including as an alternative to obesity surgery
New research covering 11 years of data presented at this year's European and International Congress on Obesity (ECOICO 2020) show that, in obese men suffering from hypogonadism (low testosterone), treatment with testosterone injections lowers their weight and improves a wide range of other metabolic parameters.

Overlap between immunology of COVID-19 and obesity could explain the increased risk of death in people living with obesity, and also older patients
Data presented in a special COVID-19 session at the European and International Congress on Obesity (ECOICO 2020) suggests that there are overlaps between the immunological disturbances found in both COVID-19 disease and patients with obesity, which could explain the increased disease severity and mortality risk faced by obese patients, and also elderly patients, who are infected by the SARS-CoV-2 virus that causes COVID-19 disease.

New obesity guideline: Address root causes as foundation of obesity management
besity management should focus on outcomes that patients consider to be important, not weight loss alone, and include a holistic approach that addresses the root causes of obesity, according to a new clinical practice guideline published in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/lookup/doi/10.1503/cmaj.191707.

Changing the debate around obesity
The UK's National Health Service (NHS) needs to do more to address the ingrained stigma and discrimination faced by people with obesity, says a leading health psychologist.

Study links longer exposure to obesity and earlier development of obesity to increased risk of type 2 diabetes
Cumulative exposure to obesity could be at least as important as actually being obese in terms of risk of developing type 2 diabetes (T2D), concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]).

How much do obesity and addictions overlap?
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs.

Should obesity be recognized as a disease?
With obesity now affecting almost a third (29%) of the population in England, and expected to rise to 35% by 2030, should we now recognize it as a disease?

Is obesity associated with risk of pediatric MS?
A single-center study of 453 children in Germany with multiple sclerosis (MS) investigated the association of obesity with pediatric MS risk and with the response of first-line therapy in children with MS.

Women with obesity prior to conception are more likely to have children with obesity
A systematic review and meta-analysis identified significantly increased odds of child obesity when mothers have obesity before conception, according to a study published June 11, 2019 in the open-access journal PLOS Medicine by Nicola Heslehurst of Newcastle University in the UK, and colleagues.

Obesity medicine association announces major updates to its adult obesity algorithm
The Obesity Medicine Association (OMA) announced the immediate availability of the 2019 OMA Adult Obesity Algorithm, with new information for clinicians including the relationship between Obesity and Cardiovascular Disease, Diabetes Mellitus, Dyslipidemia, and Cancer; information on investigational Anti-Obesity Pharmacotherapy; treatments for Lipodystrophy; and Pharmacokinetics and Obesity.

Read More: Obesity News and Obesity Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.